Poster published on April 10th at the 2021 American Association for Cancer Research (AACR) Annual Meeting shows the GP2 final 5 year immune response data from the Phase IIb clinical trial, concluding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback